Cargando…
Utility of Presepsin and Interferon-λ3 for Predicting Disease Severity and Clinical Outcomes in COVID-19 Patients
We explored the utility of novel biomarkers, presepsin and interferon-λ3 (IFN-λ3), for predicting disease severity and clinical outcomes in hospitalized Coronavirus (COVID-19) patients. In a total of 55 patients (non-critical, n = 16; critical, n = 39), presepsin and IFN-λ3 were compared with sequen...
Autores principales: | Lee, Gun-Hyuk, Park, Mikyoung, Hur, Mina, Kim, Hanah, Lee, Seungho, Moon, Hee-Won, Yun, Yeo-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377783/ https://www.ncbi.nlm.nih.gov/pubmed/37510116 http://dx.doi.org/10.3390/diagnostics13142372 |
Ejemplares similares
-
Distribution of Presepsin, Krebs von den Lungen 6, and Surfactant Protein A in Umbilical Cord Blood
por: Nam, Minjeong, et al.
Publicado: (2022) -
Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients
por: Park, Mikyoung, et al.
Publicado: (2022) -
European Kidney Function Consortium Equation vs. Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Refit Equations for Estimating Glomerular Filtration Rate: Comparison with CKD-EPI Equations in the Korean Population
por: Kim, Hanah, et al.
Publicado: (2022) -
Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis
por: Kim, Hanah, et al.
Publicado: (2017) -
Prognostic value of presepsin in adult patients with sepsis: Systematic review and meta-analysis
por: Yang, Hyun Suk, et al.
Publicado: (2018)